| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |